Investment
Features
FeesSafety
Academy
More
Pluang+

LaFleur Minerals appoints Rauni Malhi as director and grants 500,000 stock options.

Company Fundamentals
15 Sep 2026
Newsfile Corp
View Source
Bullish
LaFleur Minerals appoints Rauni Malhi as director and grants 500,000 stock options.

LaFleur Minerals Inc. appointed Rauni Malhi as a new director, effective September 15, 2026, replacing Michael Kelly who resigned. Malhi brings experience from serving on boards of other TSX Venture Exchange companies and currently works as a paralegal. The company also granted her 500,000 incentive stock options exercisable at $0.40 per share, with half vesting immediately and half after six months. This leadership change supports LaFleur's focus on advancing its Swanson Gold Project and Beacon Gold Mill in Quebec's Abitibi Gold Belt, aiming to develop district-scale gold mining operations.

LaFleur Minerals' recent board change and stock option grant provide context for market watchers. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Sep 15, 2026 16:51 WIB: out of 32 priced US stocks, 10 rose and 20 fell. Notable prices include Freeport-McMoRan Inc at USD 67.82 with a -2.21% change, Standard Lithium Ltd at USD 2.13 with a +1.91% change, and BHP Billiton Limited at USD 83.35 with a -1.64% change.

More News

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...

Market News
Bullish
1 hour ago
BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

Market News
Neutral
1 hour ago
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

Market News
Bullish
1 hour ago
K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

Market News
Bullish
1 hour ago
BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App